Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
F-star Therapeutics, Inc.
| Metric | F-star Therapeutics, Inc. Healthcare |
|---|---|
| Quality Score | 60 / 100 |
| Revenue (latest) | $21M |
| Net income (latest) | −$31M |
| Operating margin | −145.1% |
| Net margin | −147.8% |
| Return on equity | −32.3% |
| Return on assets | −25.4% |
| Return on capital (ROCE) | −27.7% |
| Debt / equity | 0.27× |
| Revenue growth (YoY) | 88.1% |
| Altman Z″ (distress) | 4.00 |
| Accruals / assets | −3.3% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.